Average Co-Inventor Count = 8.58
ph-index = 8
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Amgen Inc. (49 from 1,970 patents)
2. Other (1 from 832,680 patents)
50 patents:
1. 12473289 - Heterocyclic compounds as delta-5 desaturase inhibitors and methods of use
2. 12448396 - Methods of using heterocyclic compounds as Delta-5 Desaturase inhibitors
3. 12440491 - KRAS G12C inhibitors and methods of using the same
4. 12083121 - Substituted piperazines as KRAS G12C inhibitors
5. 11905281 - KRAS G12C inhibitors and methods of using the same
6. 11766436 - KRAS G12C inhibitors and methods of using the same
7. 11548903 - Bicyclic thiazine and oxazine derivatives as beta-secretase inhibitors and methods of use
8. 11512097 - Heterocyclic compounds as Delta-5 desaturase inhibitors and methods of use
9. 11285156 - Substituted piperazines as KRAS G12C inhibitors
10. 11090304 - KRAS G12C inhibitors and methods of using the same
11. 11021493 - 1,4-thiazine dioxide and 1,2,4-thiadiazine dioxide derivatives as beta-secretase inhibitors and methods of use
12. 10947223 - Substituted oxazines as beta-secretase inhibitors
13. 10889581 - Cyclopropyl fused thiazine derivatives as beta-secretase inhibitors and methods of use
14. 10519146 - KRAS G12C inhibitors and methods of using the same
15. 10246429 - Vinyl fluoride cyclopropyl fused thiazin-2-amine compounds as beta-secretase inhibitors and methods of use